SLN Silence Therapeutics Plc - Amer
$13.02▼ -2.18%
Healthcare
Other
After hours
$13.02▲ +0.00%
Sep 11, 7:30 PM ET
Volume 685.9K
Avg Volume (10D) 693.5K
Key Metrics & Fundamentals
Market Cap
$809.25M
P/E Ratio
–
Div Yield
–%
52W Range
4.19 - 17.58
% vs 50 MA
6.04%
% vs 200 MA
66.57%
RSI-14
47.3
MACD Histogram
-0.2200
Beta (1Y vs SPY)
1.48
Free Cash Flow
$1.52M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$13.91M
COGS
$0
Operating Exp
$13.87M
Operating Income
-$13.87M
EBIT
-$13.87M
Pretax Income
-$12.27M
Net Income
-$12.27M
EPS (Diluted)
-0.27
Price & Volume History
Loading chart…
Recent News
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading
MT Newswires · Sep 11, 2026 3:13 PM
European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
MT Newswires · Sep 9, 2026 3:30 PM
European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading
MT Newswires · Sep 8, 2026 3:28 PM
Silence Therapeutics to Participate in Three September Investor Conferences
Business Wire · Sep 2, 2026 12:00 PM
European Equities Traded in the US as American Depositary Receipts Edge Lower in Monday Trading
MT Newswires · Aug 31, 2026 3:12 PM
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Tuesday Trading
MT Newswires · Aug 25, 2026 3:15 PM
European Equities Traded in the US as American Depositary Receipts Head Lower in Tuesday Trading
MT Newswires · Aug 18, 2026 3:13 PM
Silence Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional ADSs
Business Wire · Aug 14, 2026 8:55 PM
European Equities Traded in the US Rise in Thursday Trading
MT Newswires · Aug 13, 2026 3:14 PM
Wall Street Analysts Predict a 140.06% Upside in Silence Therapeutics (SLN): Here's What You Should Know
Zacks · Aug 13, 2026 1:55 PM
Financial Overview - Income Statement
Quarterly
Mar 2026
See SLN's money flow as a full page
Social Sentiment
No Reddit posts found for SLN.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.